{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:27:00Z","timestamp":1792106820698,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cytogfr.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T06:30:39Z","timestamp":1345271439000},"page":"51-57","source":"Crossref","is-referenced-by-count":102,"title":["Emerging role of interleukin-22 in autoimmune diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Hai-Feng","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Guo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2012.07.002_bib0005","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.cr.7310106","article-title":"Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes","volume":"16","author":"Chung","year":"2006","journal-title":"Cell Research"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0010","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2008.11.009","article-title":"Decreased serum IL-22 levels in patients with systemic lupus erythematosus","volume":"401","author":"Pan","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/ard.2008.097089","article-title":"Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus","volume":"68","author":"Cheng","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2249.2009.03969.x","article-title":"Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo","volume":"157","author":"Ziesche","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0045","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","article-title":"TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice","volume":"181","author":"McKinley","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10238-011-0134-9","article-title":"Expressions of IL-22 in circulating CD4+\/CD8+ T cells and their correlation with disease activity in SLE patients","volume":"11","author":"Qin","year":"2011","journal-title":"Clinical and Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0055","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/art.30595","article-title":"Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus","volume":"63","author":"Yu","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.24220","article-title":"Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL\/6 mice","volume":"60","author":"Geboes","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0070","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.111027","article-title":"Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity","author":"da Rocha","year":"2012","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/ard.2011.152074","article-title":"Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis","volume":"70","author":"Leipe","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0080","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/gene.2011.44","article-title":"A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis","volume":"13","author":"Vandenbroeck","year":"2012","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0090","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.1001392","article-title":"IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation","volume":"185","author":"Beyeen","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0095","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.4049\/jimmunol.179.12.8098","article-title":"IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis","volume":"179","author":"Kreymborg","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-3083.2011.02583.x","article-title":"Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters","volume":"74","author":"Lavoie","year":"2011","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.2011.154013","article-title":"Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome","volume":"71","author":"Ciccia","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"Journal of Molecular Medicine (Berlin)"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0125","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","article-title":"Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells","volume":"17","author":"Wolk","year":"2006","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0140","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease","volume":"178","author":"Wolk","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-011-0772-y","article-title":"Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention","volume":"353","author":"Zhang","year":"2011","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0160","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0365","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20100061","article-title":"gammadelta T cells protect against lung fibrosis via IL-22","volume":"207","author":"Simonian","year":"2010","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0370","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1128\/JVI.00187-10","article-title":"Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection","volume":"84","author":"Guo","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","article-title":"Recent advances in IL-22 biology","volume":"23","author":"Zenewicz","year":"2011","journal-title":"International Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","article-title":"Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells","volume":"10","author":"Cupedo","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-381300-8.00001-0","article-title":"Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces","volume":"107","author":"Sonnenberg","year":"2010","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0195","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0200","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0205","doi-asserted-by":"crossref","first-page":"26377","DOI":"10.1074\/jbc.M109.007955","article-title":"New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain","volume":"284","author":"Dumoutier","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/imt.12.20","article-title":"JAK2 inhibition in murine systemic lupus erythematosus","volume":"4","author":"Tagoe","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0220","doi-asserted-by":"crossref","first-page":"e27006","DOI":"10.1371\/journal.pone.0027006","article-title":"Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathways","volume":"6","author":"Jia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0225","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/eji.200838427","article-title":"MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK\/STAT pathways","volume":"39","author":"Jiang","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2012.04.012","article-title":"Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant","author":"Arumugam","year":"2012","journal-title":"Experimental and Molecular Pathology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0235","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood-2011-02-336552","article-title":"Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis","volume":"118","author":"Noubade","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0240","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.coi.2004.09.005","article-title":"Emerging approaches for the therapy of autoimmune and chronic inflammatory disease","volume":"16","author":"Cope","year":"2004","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0245","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.coi.2006.09.004","article-title":"Immune therapies of autoimmune diseases: are we approaching a real cure?","volume":"18","author":"Chatenoud","year":"2006","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0250","doi-asserted-by":"crossref","first-page":"979258","DOI":"10.1155\/2009\/979258","article-title":"Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity","volume":"2009","author":"Kunz","year":"2009","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ncprheum0815","article-title":"Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus","volume":"4","author":"Pan","year":"2008","journal-title":"Nature Clinical Practice. Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0260","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/BOR.0b013e328304b6b5","article-title":"IL-17 and the Th17 lineage in systemic lupus erythematosus","volume":"20","author":"Garrett-Sinha","year":"2008","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0270","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","article-title":"IL-17 as a future therapeutic target for rheumatoid arthritis","volume":"5","author":"van den Berg","year":"2009","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0275","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-011-0841-4","article-title":"IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis","volume":"90","author":"Pollinger","year":"2012","journal-title":"Journal of Molecular Medicine (Berlin)"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0280","doi-asserted-by":"crossref","first-page":"187258","DOI":"10.1155\/2012\/187258","article-title":"Expression of IL-17 IL-23 and their receptors in minor salivary glands of patients with primary Sjogren's syndrome","volume":"2012","author":"Mieliauskaite","year":"2012","journal-title":"Clinical & Developmental Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0285","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting IL-17","author":"Girolomoni","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.02.003","article-title":"Anti-cytokine vaccination: a new biotherapy of autoimmunity?","author":"Semerano","year":"2012","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0295","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.4049\/jimmunol.1100482","article-title":"IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis","volume":"187","author":"Ke","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0300","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/eji.200838655","article-title":"IL-22 inflammation: leukin\u2019 through a glass F onion","volume":"38","author":"Zenewicz","year":"2008","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ibd.20315","article-title":"Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status","volume":"14","author":"Schmechel","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jdermsci.2010.03.018","article-title":"Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy","volume":"58","author":"Lo","year":"2010","journal-title":"Journal of Dermatological Science"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cytogfr.2010.10.007","article-title":"Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease","volume":"21","author":"Ouyang","year":"2010","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0320","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0325","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7150\/ijbs.3967","article-title":"Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway","volume":"8","author":"Feng","year":"2012","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0335","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0340","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.1102224","article-title":"IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice","volume":"188","author":"Van Belle","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0345","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/art.30469","article-title":"Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation","volume":"63","author":"Marijnissen","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0350","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.177.6.3635","article-title":"Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats","volume":"177","author":"Chang","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.07.002_bib0355","first-page":"43","article-title":"Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3","volume":"1","author":"Pan","year":"2004","journal-title":"Cellular & Molecular Immunology"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610112000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610112000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T23:28:56Z","timestamp":1562110136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610112000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1359610112000627"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2012.07.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}